FINWIRES · TerminalLIVE
FINWIRES

29Metals Delaying Access to Xantho Extended is Painful But Prudent Call, Jarden Says

By

29Metals' (ASX:29M) decision to delay the restart of mining at its Xantho Extended orebody in Western Australia is painful but prudent given the frequency of production disruptions at the site, Jarden said in a Thursday note.

An ongoing geotechnical review has pinpointed a need for alternate level access development to mitigate interactions with higher-stress zones and cut the risk of further interference with production.

The equity research firm noted that Xantho Extended is a major source of high-grade polymetallic feed at the Golden Grove mine, as well as the zinc, gold and silver by-product credits that support the operation's cost structure.

Meanwhile, 29Metals' Capricorn Copper mine remains suspended and will need considerable additional funding to restart, "representing a further call on an already stretched balance sheet," Jarden said.

The equity research firm maintained an underweight rating on 29Metals and cut its price target on the company to AU$0.32 from AU$0.38.

"We seek greater operating consistency at Golden Grove, a credible pathway to restart Capricorn Copper, and positive [free cash flow] generation to become more constructive in our view," it said.

Related Articles

Asia

Netwealth's FUA Net Flows in Fiscal Q4 Likely to See Seasonal Step-up, Jarden Says

Netwealth Group's (ASX:NWL) funds under administration (FUA) net flows are likely to see a seasonal step-up in the fiscal fourth quarter, which would see the fiscal 2026 outcome tracking slightly ahead of its guidance range, Jarden said in a Thursday note.It raised its earnings-per-share forecasts by 0.1% for fiscal 2026, 1.5% for fiscal 2027, and 1.6% for fiscal 2028.Jarden also flagged the risk of higher cost growth due to the enforceable undertaking, regulatory scrutiny, and recent treasury consultations.The investment firm retained its neutral recommendation on Netwealth Group and raised the price target to AU$25.70 from AU$25.35.Netwealth Group's shares gained 1% in recent Friday trade.

ASX:NWL
Asia

CDL Hospitality REIT Issues Stapled Securities as Payment of Management Fee

CDL Hospitality REIT (SGX:J85) issued 5.5 million stapled securities to its manager, H-REIT Manager and HBT Trustee-Manager as payment of management fee for 2025, according to a Friday filing with the Singapore Exchange.Nearly 5 million stapled securities were issued to the H-REIT Manager at SG$0.8199 per security as 80% payment of its performance fee for 2025.Meanwhile, 535,179 securities were issued to HBT Trustee-Manager at SG$0.8199 per security as payment of 80% of performance fee for 2025.

SGX:J85
Asia

Syntara's Myelofibrosis Drug Candidate Shows 'Significant' Commercial Potential, Euroz Hartleys Says

Syntara's (ASX:SNT) Amsulostat drug candidate has a "unique" position in the myelofibrosis landscape and "significant" commercial potential, Euroz Hartleys said in a Thursday note.Myelofibrosis is a blood cancer characterized by scar tissue formation or fibrosis in the bone marrow.Dr Adam Craig, Syntara strategic adviser and an industry leader in myelofibrosis, noted Amsulostat's mechanism targeting fibrosis, with the potential as a disease-modifying therapy, rather than just a symptomatic treatment.Craig said that Amsulostat's safety profile differs from current therapies and is unaware of any other drug taking a similar approach.Additionally, Craig said that Amsulostat's mechanism requires time for effect, as fibrosis evolves gradually. Patient responses observed at six months are complemented by a continuing improvement over time.Euroz Hartleys reaffirmed its speculative buy recommendation and AU$0.22 price target on Syntara.Syntara shares fell 1% in afternoon trade on Friday.

ASX:SNT